2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Revenue | $407M | $465M | $419M | $343M | $326M |
Cost of Revenue | $285M | $347M | $443M | $426M | $285M |
Gross Profit | $122M | $117M | -$24M | -$83M | $42M |
Gross Profit % | 30% | 25% | -5.7% | -24% | 13% |
R&D Expenses | $32M | $67M | $62M | $40M | $28M |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Net Income | -$53M | -$182M | -$366M | -$338M | -$160M |
Dep. & Amort. | $13M | $22M | $33M | $48M | $23M |
Def. Tax | $1.8M | $4.2M | $0 | $0 | $0 |
Stock Comp. | $27M | $28M | $34M | $29M | $24M |
Chg. in WC | -$32M | -$180M | -$54M | $115M | -$4M |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Cash | $159M | $733M | $310M | $191M | $132M |
ST Investments | $0 | $0 | $0 | $0 | $0 |
Cash & ST Inv. | $159M | $733M | $310M | $191M | $132M |
Receivables | $36M | $44M | $34M | $32M | $27M |
Inventory | $122M | $242M | $236M | $130M | $113M |
BYND achieved two consecutive quarters of year-over-year net revenue growth in the second half of 2024, following over two years of declining sales. Full-year 2024 net revenues were $326.5 million, down 4.9% from 2023, with a significant slowdown in the rate of decline.
The company reduced operating expenses by over $50 million in 2024 (excluding a $7.5 million settlement) and improved adjusted EBITDA, with a Q4 adjusted EBITDA loss of $26 million compared to a loss of $125.1 million in the prior year.
For 2025, BYND expects net revenues between $320 million and $335 million, gross margin of approximately 20%, and operating expenses between $160 million and $180 million. The company aims to achieve run-rate EBITDA-positive operations by the end of 2026.
Key strategic goals for 2025 include maintaining comparable year-over-year net revenues, improving gross margin to approximately 20%, further reducing operating expenses, and strengthening the balance sheet through liquidity improvements and capital structure optimization.
BYND continues to focus on innovation, expanding distribution in under-indexed segments, and addressing consumer concerns about health and product simplicity. The company is also consolidating its production network and investing in automation to drive efficiency and gross margin expansion.